Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-06-04

FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for LOXAPINE (loxapine) by Actavis Pharma, Inc., resulting in an updated marketing authorization for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)